Bionano CEO presents at H.C. Wainwright conference; no financial disclosures in furnished text

Bionano Genomics, Inc.

Al Luderer, Chairman and Interim CEO, presented September 14, 2026 at H.C. Wainwright 28th Annual Global Investment Conference.
Furnished presentation (Exhibit 99.1) contains no specific financials, guidance, or operational updates in the available text.
Stock trades on Nasdaq Capital Market under BNGO; company based in San Diego, CA.
Filing is a routine investor-relations disclosure; no new quantitative data disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.